Psychopharmacology Maastricht
The psychopharmacology department at Maastricht University focuses on the cognitive, behavioral, and biological effects of various substances, ranging from pharmaceutical to recreational drugs.
Learn More
Congratulations to the NEW Dr. Eline C. H. M. Haijen!
After successfully defending her PhD thesis entitled: “Exploring the Adult ADHD Treatment Landscape: From Current Practices to Psychedelic Microdosing and Novel Screening Approaches.” In her thesis, she looks at novel approaches of treating ADHD with LSD microdosing.
Watch the defense here!Congratulations to Lilian Kloft-Heller for being awarded the Collaborative Innovative Projects grant
From The Science Committee of the Faculty of Law for her research titled "Effects of Intoxication on Legal Decision-Making in Suspects: Developing Experimental Tools Using Virtual Reality"
Across two studies, Lilian will assess how intoxicated suspects make decisions on their rights and strategies throughout the custodial process. One study will be a field study in which self-intoxicated participants (alcohol) will take part. This study will be conducted in a bar or at a festival. The second study is a lab experiment to examine effects of acute cannabis intoxication on suspect decision-making.
Meet our Department!
The scientists in our lab come from many countries and backgrounds, all with highly unique research abilities. Come meet the people that make up the Psychopharmacology Department.
Learn MoreParticipate in our studies!
We're always conducting research in our department and we're frequently looking for participants to be a part of science! If you're interested, look at the studies that we are currently conducting.
View All Studies
Our Scientists
Dr. Natasha Mason
Neuroadaptations, Plasticity, Psychedelics
My research is driven by my desire to find effective treatments for psychiatric disorders, particularly anxiety, depression, and post-traumatic stress disorder.
Katharina Lege, MSc
Cannabinoids, Neuroimaging, Consciousness
Coming from a background of psychology and clinical neuroscience, I developed a strong interest in altered states of the mind as in mediation or yoga practices.
Dr. Johannes Reckweg
5-MeO-DMT, Neuropsychopharmacology, Therapy
I am Johannes, a PhD from Germany. After receiving my Bachelor’s degree from the Rijksuniversiteit Groningen, I came to Maastricht for my Master in Neuropsychology.
Dr. Kim Kuypers
Microdosing, Cognition, Nutrition
My research focuses on the neurobiology of flexible cognition, empathy, and well-being.
Dr. C. Rob Markus
I became an expert on the relation between stress, brain (gene) vulnerability and the development of cognitive-affective complaints/disorders as well as in testing (claims about) dietary treatment/assessment methods.
Lorena Guerra, MSc
I am Lorena, a PhD candidate from Brazil with experience working on preclinical and clinical research.
Aedan O’Shea, MSc
I have a long standing interest in unravelling the therapeutic mechanisms of Psychedelics, and in this project I will investigate the effect of Psychedelic drug exposure in humans on miRNA’s transported in neuron-derived Extracellular Vesicles...
Zeus Tipado, MSc
My neuroscience research is focused on perceptual experiences of psychedelics, specifically visual experiences while under DMT.
Prof. Arjan Blokland
Learning & Memory, Acetylcholine, Cognition
I studied Psychology at the Radboud University (Nijmegen, NL). After receiving my PhD in Maastricht in 1992, I did a post doc at the University of Cambridge in 1992.
Psychedelic Research
Spontaneous and deliberate creative cognition during and after psilocybin exposure
creativity, Cognition, Psilocybin
→
Me, myself, bye: regional alterations in glutamate and the experience of ego dissolution with psilocybin
→
Psilocybin induces acute and persisting alterations in immune status and the stress response in healthy volunteers
→
Microdosing psychedelics: More questions than answers? An overview and suggestions for future research
→
The use patterns of novel psychedelics: experiential fingerprints of substituted phenethylamines, tryptamines and lysergamides
→
Cannabis Research
Medicinal Δ9-tetrahydrocannabinol (dronabinol) impairs on-the-road driving performance of occasional and heavy cannabis users but is not detected in Standard Field Sobriety Tests
→
Intoxication by a synthetic cannabinoid (JWH-018) causes cognitive and psychomotor impairment in recreational cannabis users
Cognition, Psychomotor, Cannabis
→
Cannabis induced increase in striatal glutamate associated with loss of functional corticostriatal connectivity
Glutamate, Functional Connectivity, Cannabis
→
Cognition and motor control as a function of 9-THC concentration in serum and oral fluid: Limits of impairment
→
Get in Touch
We are always up for communicating with people that have interesting ideas or questions. If you want to contact our department, please reach out using this form below.